Peptide-based approaches can target both types of tolerance
Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: in-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment
Why this story matters now Even though evidence is still early and more research is needed, GLP-1 medications are now part of a broader conversation about cancer prevention, survivorship, treatment tolerance, and long-term health after breast cancer
Pattappa G, Krueckel J, Schewior R, Franke D, Mench A, Koch M, Weber J, Lang S, Pfeifer CG, Johnstone B, Docheva D, Alt V, Angele P, Zellner J
Are there any side effects of glutathione IV drip